• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[弥漫性毒性甲状腺肿患者止血障碍的发病机制的几个方面]

[Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter].

作者信息

Oleĭnik V A, Matiashina G I

出版信息

Ter Arkh. 1988;60(9):43-6.

PMID:3217879
Abstract

Components of the kallikrein-kinin system of the blood and some hemostatic indices were studied in parallel in 32 patients with diffuse toxic goiter. A decrease in the levels of prekallikrein, kininogen, the activity of kallikrein and kininase inhibitors in the blood plasma of the examinees resulted in raised activity of the kallikrein-kinin system in decompensated thyrotoxicosis. Hemostatic changes were characterized by signs of chronic disseminated intravascular coagulation. It was shown that kinin formation and blood coagulation were correlated. A certain parallelism in the increment of the activity of the kinin system and disorders of hemocoagulation was noted with an increase in a degree of severity of thyrotoxicosis. A tendency to improved indices was also noted after thyrostatic therapy.

摘要

对32例弥漫性毒性甲状腺肿患者同时研究了血液中激肽释放酶-激肽系统的成分和一些止血指标。受检者血浆中前激肽释放酶、激肽原、激肽释放酶和激肽酶抑制剂活性水平降低,导致失代偿性甲状腺毒症时激肽释放酶-激肽系统活性升高。止血变化以慢性弥散性血管内凝血迹象为特征。结果表明,激肽形成与血液凝固相关。随着甲状腺毒症严重程度的增加,激肽系统活性增加与血液凝固紊乱之间存在一定的平行关系。甲状腺功能抑制治疗后也注意到指标有改善的趋势。

相似文献

1
[Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter].[弥漫性毒性甲状腺肿患者止血障碍的发病机制的几个方面]
Ter Arkh. 1988;60(9):43-6.
2
[Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].弥漫性毒性甲状腺肿患者在抗甲状腺药物及普罗迪菌素影响下血液激肽释放酶-激肽系统的变化
Vrach Delo. 1989 Apr(4):31-3.
3
[The pathogenesis and treatment of infectious-toxic shock].
Vrach Delo. 1991 Nov(11):110-3.
4
[Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].[普罗迪菌素对弥漫性毒性甲状腺肿患者血液激肽释放酶-激肽系统活性的影响]
Probl Endokrinol (Mosk). 1986 Jul-Aug;32(4):7-10.
5
[Blood plasma kallikrein-kinin system in acute intravascular hemolysis].[急性血管内溶血中的血浆激肽释放酶-激肽系统]
Sov Med. 1981(10):14-8.
6
[Kallikrein-kinin system and the hemorrhagic syndrome in acute leukemia].
Probl Gematol Pereliv Krovi. 1981 Nov;26(11):22-5.
7
[Changes in the hemostatic system indices of patients with chronic kidney failure under the influence of enterosorption and plasmapheresis].[肠吸附和血浆置换对慢性肾衰竭患者止血系统指标的影响]
Ter Arkh. 1994;66(8):57-60.
8
Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).落叶型天疱疮(巴西落叶型天疱疮)患者血浆和组织激肽释放酶、血浆激肽酶II及唾液激肽释放酶活性增加。
Br J Dermatol. 2005 Apr;152(4):650-7. doi: 10.1111/j.1365-2133.2005.06427.x.
9
[Activation of the blood kallikrein-kinin system in disseminated intravascular coagulation in rats. The significance of the pulmonary component and an attempt at correction with aspirin].
Biull Eksp Biol Med. 1984 Sep;98(9):278-81.
10
Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.由于凝血因子XII基因突变Thr309Lys导致的遗传性血管性水肿中的激肽释放酶-激肽系统与纤维蛋白溶解
Blood Coagul Fibrinolysis. 2009 Jul;20(5):325-32. doi: 10.1097/MBC.0b013e32832811f8.